GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
120.19
+1.93 (1.63%)
At close: Oct 6, 2025, 4:00 PM EDT
120.15
-0.04 (-0.03%)
After-hours: Oct 6, 2025, 7:21 PM EDT
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$362,321
Profits / Employee
$1,406
Market Cap
3.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Dec 31, 2020 | 872 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WGS News
- 5 days ago - GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award - Business Wire
- 6 days ago - GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth - Business Wire
- 11 days ago - GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference - Business Wire
- 18 days ago - GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors - Business Wire
- 4 weeks ago - GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Seer Appoints Isaac Ro to its Board of Directors - GlobeNewsWire
- 2 months ago - Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewsWire
- 2 months ago - GeneDx to Participate in Upcoming Investor Conferences - Business Wire